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Summary.-Records of 3085 patients registered with breast cancer at the Mersey
Regional Cancer Registry have been analysed to evaluate the relative importance of
possible prognostic factors. In a subgroup of 1759 patients, clinical stage and histo-
logical grade are shown to be strongly related to survival after treatment. In addition
histological grade is related to the distribution of times to death after treatment. The
results of this and 3 other studies have implications for the design and analysis of
clinical trials in the primary treatment of breast cancer.
SINCE the introduction of histological
grading in breast cancer by von Hause-
mann (1892) its contribution to knowledge
of the disease and its appropriate role in
the choice of treatment has been a matter
of dispute. A primary difficulty with most
grading methods has been the lack of
reproducibility in the assessment ofgrade,
both by different pathologists and by the
same pathologist on different occasions
(Foote, 1959). Not unreasonably these
difficulties have led to some resistance to
the wide adoption of one ofthese methods
for the purpose ofguidance in the manage-
ment of treatment.
Nevertheless Bloom (1950; 1-962) and
Bloom & Richardson (1957) showed how
successful grading by one pathologist
could be in predicting survival. Schi0dt
(1966) reviewed many of the different
grading methods proposed, and found
Bloom & Richardson's (1957) method
conveniently simple to apply. Both
Schiodt and Bloom found the repro-
ducibility of grade on repeated assess-
ments by the same pathologist to be
acceptably high. This method of grading
has since been adopted by WHO (Scarff
& Torloni, 1968). Schi0dt (1966) and
Bunting et al. (1976) have both confirmed
the close relationship of grade to length
of survival following treatment. Hart-
veit (1971) has discussed another
grading method for which she claims a
greater predictive power than Bloom's
method, but her results are as yet un-
confirmed.
Since 1958 one of us (E.M.McC.) has
been grading breast carcinomas according
to Bloom and Richardson's method, using
histological material submitted to the
Mersey Regional Cancer Registry by
pathologists in the Liverpool region,
North WVales and the Isle of Man. This
paper examines the survival of patients
treated by radical surgery in relation to
the histological grade and other prognostic
factors. Recently statistical methodology
has been developed to allow simultaneous
assessment of several prognostic factors in
survival. One such method (Brown, 1975)
has been used in this investigation.
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Data
The study is based on the records ofthe
Mersey Regional Cancer Registry (MRCR)
for the years 1961-68, which registers from
a population of an area comprising the
Liverpool Regional Hospital Board, the
5 old counties of North Wales (Anglesey,
Caernarvonshire, Denbighshire, Flintshire,
and Merionethshire) and the Isle of Man.
During this period a total of 7493 cases of
carcinoma of the breast were registered,
but this study is limited to 3085 patients
who were initially treated by radical
surgery only. Of these cases, histological
material in the form of a duplicate section
was available at the Cancer Registry for
1759 patients classified as having infiltrat-
ing carcinoma. Scarff & Torloni (1968)
recommend the term "infiltrating car-
cinoma" to be used to include all car-
cinomas ofthe breast except intraduct and
intralobular non-infiltrating carcinomas,
and the following general histological
variants ofinvasive carcinoma: medullary
carcinoma, papillary carcinoma, cribiform
carcinoma, mucous carcinoma, lobular
carcinoma, squamous-cell carcinoma and
Paget's disease of the breast. Thus the
group of infiltrating carcinoma contains
a large range of malignant epithelial
growths, from well-differentiated adeno-
carcinoma to completely undifferentiated
carcinoma.
The grading system was that recom-
mended by Bloom & Richardson and took
account of the following histological
criteria:
(1) Tubule formation
(2) Hyperchromatism and mitosis
(3) Irregularity of size, shape and stain-
ing ofnuclei.
Well-marked tubule formation is charac-
teristic of a high degree of differentiation
and indicates a favourable prognosis, and
1 point is awarded if the section shows
well-marked tubule formation, 2 points if
tubule formation is moderate and 3 points
if there is little or no differentiation.
The greater the number of hyper-
chromatic or mitotic nuclei the worse the
prognosis. One point is awarded if only an
occasional hyperchromatic nucleus or
mitotic figure is seen per high-power field,
2 points if there are 2-3 such figures in
most fields and 3 points if the number is
higher. One point is awarded if the nuclei
are uniform in size, shape and staining, 2
points if there is moderate variation and
3 points if pleomorphism is marked.
The points allocated for each of the 3
criteria are added together; a total of 3-5
is graded I, 6-7 points graded II, and 8-9
points is graded III.
In most cases one section was sufficient
for grading, but with larger growths it was
sometimes necessary to examine several
sections. When there was a definite varia-
tion in grade within a tumour then the
grading of the most malignant area was
allotted.
TABLE I.-Items used in the analyses and the selected groups
Item of information
Prognostic factors-
Age of patient:
Size of tumour at presentation:
Clinical stage of disease:
Histological grade of tumour:
Treatment-
Type of initial treatment (radical):
Year of initial treatment:
Response-
Length of survival*:
Survival status:
Groups
<45 yrs; 45-54 yrs; 55 yrs plus;
Unknown; < 5 cm; 5 cm+
Grade I; Grade II; Grade III; unknown
Stage 1; Stage 2; Stage 3.
Surgery
1961-1968 inclusive
Each completed year of survival
Alive; Dead, cause unknown; Dead, no malignancy;
Dead, malignancy; Dead, date unknown; Not known
whether dead or alive
*Measured from date of initial treatment.
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The items of information, in the coded
form on magnetic tape which is used in
this study, are shown on Table I. All these
items were checked with the more detailed
registry case sheets and found to be con-
sistent. However, certain of the items are
open to errors which are inherent in any
retrospective survey.
For example, the clinical assessment of
the size ofthe tumour was copied from the
hospital notes whenever it was recorded,
but frequently the clinician had failed to
FiG. 1.-Photomicrograph of a Gra(le 1 caIcil1oIna (H andl E. x 60)
FIcG. 2.- Photomicrograph of a Grade 2 carcinoma
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FIG. 3.-Photomicrograph of a Grade 3 carcinoma (H and E. x 170).
record this factor. It is recognised by most
clinicians that the measurement cannot
be very accurate. Clinical staging was
assessed using the "Manchester" system.
The stage was usually decided by non-
medical staffofthe registry on reading the
hospital notes and there is some evidence
to show that this is more accurate than
staging done infrequently by junior doc-
tors. The staff had been trained for this
work and probably the allotted stage can
be accepted as the best information avail-
able. Histological grade had been decided
by the one pathologist throughout
(E.M.McC.), at the time of the initial
registration. The grade, of course, was
allotted only if a histological section had
been submitted to the Registry. Photo-
micrographs of breast tumours typical of
the grade given are shown (Fig. 1, 2 and 3).
An analysis of the early years of grading
(1958-60) showed considerable variation
of the proportions of the grades, but for
the years of analysis these were more
stable (Table II). Disease status at death
(presence or absence ofmalignant disease)
is thought to be a reasonably accurate
record, being based on clinical assessment
summarized in the annual follow-up infor-
mation on the patient. It should be more
TABLE II.-Distribution ofhistological grade by year ofdiagnosis*
Year
of
diagnosis
1961
1962
1963
1964
1965
1966
1967
1968
Total
Histological grade
t K
It
32 (13-1)
28 (13-6)
56 (21-5)
56 (17-7)
80 (22-0)
116 (28.4)
99 (25-1)
92 (25.4)
559
II
85 (34 8)
79 (38*3)
96 (36 9)
128 (40*4)
119 (32-7)
124 (30 4)
134 (33*9)
114 (31-5)
879
III
128 (52.5)
99 (48-1)
108 (41-5)
133 (42 0)
165 (45 3)
168 (41-2)
162 (41-0)
156 (43-1)
1119
Unknown
643
656
722
624
516
571
569
635
4936
Total
888
862
982
941
880
979
964
997
7493
* This table is not restricted to radically treated patients but includes
all patients diagnosed 1961-1968.
t °/O of the total number of tumours allotted a grade during the year are in parentheses.
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reliable than the cause of death given on
the death certificate.
Statistical analysis
The 4 prognostic factors used in this
study are listed in Table III. A patient
TABLE III. Distribution of prognostic
factors in the study
Age <45
45-54
55 plus
Tumour size < 5 cm
5 cm plus
unknown
Clinical stage 1
2
3
Histological grade
I
II
III
unknown
All
patients
(3085)
427 (13-8)
782 (25 3)
1876 (60.8)
309 (10 0)
598 (19-4)
2178 (70.6)
1565 (50 7)
965 (31-3)
555 (18-0)
384 (12-4)
616 (20 0)
759 (24.6)
1326 (43 0)
Subgroup
with sections
available
to grade
(1759)
242 (13-8)
445 (25.3)
1072 (60 9)
212 (12-1)
368 (20 9)
1179 (67.0)
854 (4856)
591 (33.6)
314 (17-9)
384 (21-8)
616 (35 0)
759 (43-1)
-( )
may belong to any one ofthe possible 108
(=3 x 3 x 3 x 4) prognostic groups. A
cross-tabulation of "survival status"
against length of survival is obtained for
each prognostic group. As a by-product,
the cross-tabulations of the prognostic
factors themselves are also obtained. The
relationship between the various prog-
nostic factors and survival can be assessed
by studying appropriate life-tables
(Armitage, 1971) which are formed from
the cross-tabulations. Two types of life-
table are formed: that considering all
causes of death together, and that con-
sidering deaths from malignant disease
only, other deaths being counted as lost to
follow-up. Survival curves were drawn to
illustrate the information in these life-
tables and several are presented in the
Results section. These figures and also the
tables of survival rates refer to all causes
ofdeath.
For a more formal assessment of the
relationships between the prognostic fac-
tors and survival a mathematical model
must be introduced. A model of Brown
(1975) seems appropriate for our data and
a description is given in Appendix I. The
analyses of the data using this model are
performed by a programming package
known as GLIM, that is available on the
Liverpool University computer. The input
for the programme consists of extracts
from the 108 cross-tabulations mentioned
earlier in this section. Each analysis (all
causes ofdeath and deaths from malignant
disease) was performed on all 3085 records
and repeated for the subset of 1759
records for which a histological grade had
been allocated. The results of the analysis
of deaths from all causes are described in
some detail in this paper, and the results
of death from malignant disease are
described briefly in Appendix 2.
RESULTS
Table III shows the distribution ofeach
prognostic factor among the 3085 patients,
and also among the subgroup of 1759
patients allocated a tumour grade. Two
points that might be stressed are that the
size of tumour was recorded in only 30%
of the records and that the distribution of
the 1759 patients over histopathological
grades I, II, and III was in the approxi-
mate 3:5:6 ratio.
Table IV shows the 5-year survival
rates (all causes of death considered)
estimated from life-tables for each prog-
nostic factor. Since the most important
factors appear from this table to be
clinical stage and histological grade, the
life-tables for each combination of clinical
stage and histological grade were also
computed. Figs. 4, 5 and 6 show the
survival curves plotted from these life-
tables on a logarithmic scale.
The results of the analysis using the
mathematical model (Brown, 1975) are
presented in detail in Appendix 2. These
results indicate that, of the 4 prognostic
factors considered, only histological grade
and clinical stage are in fact of import-
ance; moreover in this series histological
grade is found to be more important than
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TABLE IV.-Survival (oo) at 5 and 10 years by prognosticfactor
Age <45
45-54
55 plus
Tumour size unknown
<5 cm
5 cm pltus
Clinical Stage 1
2
.3
Histological Gradel I
II
III
uinknown
All records
(3085)
5 yr 10 yr
67-7 51-9
63-5 47-4
57-7 33-8
59-3 38-8
64-1 41-8
62-0 41-5
67-6 47-4
55-7 34-7
47-9 26-5
7709 56-3
64-2 39.4
50-6 33-3
59.0 38-6
Subgroup with grade
(1759)
5 yr l0 yr
69-0 52-8
65-9 48'3
57-9 34-4
60-6 390
63-2 434
62-7 43-6
68-1 47-8
57-6 36-0
49 7 28-8
77 9 56'3
64-2 39 4
50-6 33-:
100
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YEARS FOLLOWING TREATMENT
Fie. 4. Survival curves. Histological Grade I
Stage 1; - Stage 2; ..... Stage 3.
clinical stage. In addition the analysis
shows that the distribution of deaths over
the period after treatment varies according
to the histological grade but not according
to the clinical stage. This phenomenon is
illustrated by plotting the "risk of death"
against time for the 3 histological grades
and 3 clinical stages. (The "risk of death"
is defined as the number of deaths during
one year expressed as a proportion of the
numbers of persons at risk during that
year.) The plots are shown in Fig. 7 and 8.
In Fig. 7 it can be seen that the peak risk
for patients with Grade III tumours is
reached at an earlier period (between the
first and second year after treatment) than
for those with lower grade tumours. In
YEARS FOLLOWING TREATMENT
FTh. 5. Survival curves. Histological Grade II.
Stage 1; ---- Stage 2; ..... Stage 3.
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49
innL. S. FREEDMAN ET AL.
.20
.18
. 16
. 14
: . 12
E-4
a .10
0 .08
:<. 06
.04
.02
0-1 1-2 2-4 4-6 6-8 8-10
YEARS FOLLOWING TREATMENT
FIa. 7. "Risks of Death" for 3 Histological Grades.
Grade I; - Grade II; ..... Grade III.
.20
.18
. 16
. 14
. 12
S .10
O .08
X .06
.04
.02
0-1 1-2 2-4 4-6 6-8 8-10-
YEARS FOLLOWING TREATMENT
FIG. 8.-"Risks of Death" for 3 Clinical Stages.
Stage 1; --- Stage 2; ..... Stage 3.
contrast, Fig. 8 shows no such difference
between the groups of patients with
different clinical stages of disease.
DISCUSSION
The results ofthis retrospective analysis
suggest the importance of histopatho-
logical grade as a prognostic factor in
breast cancer. Our results are in basic
agreement with those of Bloom &
Richardson (1957), Schi0dt (1966) and
Bunting et al. (1976), but differences in
some of the details need to be discussed.
The distribution over Grades I, II and III
in our series was in the ratio 3:5:6,
whereas in the 3 reports cited above the
ratios arenearer 1:2: 1. It seemslikely that
this difference is due to the subjective
nature of grading, and indicates that
Bloom's method, although the most
clearly documented of available methods
(Schi0dt, 1966), may be liable to sub-
stantial differences in interpretation
among pathologists. The alternative ex-
planation of a real difference in the
tumours in thisgeographical region cannot
be completely ruled out. Although, over
the period of this study (1961-1968) the
ratios are more stable than in the earlier
years, the ratios at the end of our series
can be seen in Table II to be different
from those at the beginning. The changes
in the ratios are most pronounced at the
start of the series, and presumably this
coincided with the period in which the
pathologist was gaining experience in this
grading method. Our analysis, unlike
those of Bloom (1962) and Bunting et al.
(1976) shows histological grade to be more
important than clinical stage. However,
this is possibly a reflection of the in-
adequate recording by clinicians of the
clinical stage. Despite all these differences,
the relationship between histological
grade and prognosis holds as strongly in
this study as in the 3 previous studies.
Bloom, Bunting and Schi0dt all com-
ment on the different time-patterns of
deaths according to tumour grade. This is
confirmed in our study. For Grade III
tumours, the peak rise ofdeath is between
the first and second year after treatment,
and for Grades I and II tumours the risk
of death reaches its peak between 4-6
years after treatment. However, further
analysis (not described here) suggests that
the position of peaks in these latter two
groups may depend on the clinical stage,
but a larger number of patients and a
longer follow-up would be required to
clarify this point.
The importance of Bloom's histological
grade as a prognostic factor, as now
-0-
- 4boo-
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demonstrated in 4 independent reports
involving large numbers of breast-cancer
patients, raises issues on the design,
analysis and interpretation of clinical
trials in the primary management of this
disease.
By including histological grade as a
covariate in the statistical comparison of
two treatments (Armitage & Gehan, 1974)
we would make such a comparison more
precise. For example, it can be shown that
if Bloom's results (1962) hold true in a
trial of treatment for Clinical Stage 2
disease, including histological grade in the
analysis would be equivalent to having
13% more patients in the trial (see
Appendix 3). Thus, by arranging for the
tumours to be graded by a pathologist, it
should be possible to obtain an answer
from the trial at an earlier date. In addi-
tion such a trial could tell us whether the
difference in response to each treatment
was the same for high-grade and low-
grade tumours. For example, cytotoxic
therapy adjuvant to surgery may be more
effective than surgery alone for high-
grade tumours but not for low-grade
tumours. Fisher & Fisher (1977) have
recently made a similar recommendation
that histological information be used in
breast cancer trials.
It should be noted that if histo-
logical grade is used in the analysis of
breast-cancer studies based on survival
data, comparing the survival according to
grade by the logrank test (Peto et al.,
1977) is not particularly appropriate,
since the "risks of death" (or hazards) for
the different grades do not bear constant
ratio to each other over time. This point is
illustrated in Fig. 7. In such a case time-
dependent variables should be introduced,
and among others Brown's (1975) method
used in this study might be considered.
However, it may still be appropriate to
compare the treatment groups them-
selves by the logrank test after the appro-
priate stratification (Peto et al., 1977).
The data presented here also have
implications for the results of trials in
breast cancer which have been reported
after follow-up times of at most 3 years
(Fisher et al., 1975; Bonadonna et al.,
1976; Multicentre Breast Cancer Chemo-
therapy Group, 1977). Differences be-
tween treatments found in these studies
may reflect only the response of Grade III
tumours (Fig. 7). It may be too early to
say whether tumours of low grades
respond in the same way.
We are grateful to Dr J. Haybittle for his helpful
criticisms and to Mr C. West who helped with some
of the computing. We also thank Miss Sheila Murray
for typing the paper.
APPENDIX I. APPLICATION OF BROWN S
MODEL
We illustrate the method using the
simple case where the relationship be-
tween survival and a single prognostic
factor is to be assessed. We suppose that
the prognostic factor has 2 possible
values. The time after the first treatment
is divided into a number of periods. In
this study 6 periods were chosen: 0-1 year,
1-2 years, 2-4, 4-6, 6-8 and 8-10 years.
To describe Brown's model it is neces-
sary to introduce the idea of a "hazard".
The hazard for a particular period is
defined as the probability that a patient
who has survived to the beginning of the
period will die at some time during that
period. Thus for a period of one year the
hazard is identical to the "risk of death"
which was introduced in the Results
section ofthe main text, while for a period
of 2 years the hazard is twice the risk of
death.
Let the hazard for a patient who has
value i of the prognostic factor (where
i=1, or 2) and is at risk during Period t
(where t= 1, 2, 3, 4, 5, or 6) be denoted by
Pit. Brown's model postulates that
logitPit- log( Pit) =M+T'i+Tt+(VT)it
(i 1, 2; t=1, 2, 3, 4, 5, 6) (Al)
where M is the overall effect, Vi is an
effect due to the ith value of the prog-
nostic factor, Tt is an effect due to the tth
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time periocl and (VT)it is an effect due to
the "interaction" between the prognostic
factor and the periods.
The values of M, Vi, Tt and (7T)it can
be so chosen that the data used in this
study are fitted exactly by the model.
However, if certain of the terms on the
right-hand side ofexpression (Al) are con-
strained to be equal to zero, the data will
not necessarily be fitted exactly. The
goodness-of-fit of such a constrained
model is measured by the value of twice
the maximized log-likelihood; whenever
this value is significantly large, the
corresponding model is rejected as an
inadequtate description of the data. In our
example the constrained mnodels ofinterest
are:
logit Pit- M (A2a)
logit Pit =M -Tt (A2b)
logit Pit =M Vi+Tt (A2c)
The time-effect Tt is regarded as a basic
component of the model, and the prog-
nostic factor effect V1 is therefore never
included in the model without Tt. The
analysis proceeds by searching through
these models to find the simplest (i.e. the
model with the least terms) which is
judged an adequate description of the
data. Iffor example model (A2c) is judged
to be an adequate description, it follows
that the interaction terms (VT)it are not
really required.
Another way of viewing the results is to
consider how much improvement is
achieved in the goodness-of-fit by adding
extra terms into the model. For example,
if the goodness-of-fit criterion for Model
A2c is not much smnaller than that for
Model A2b, it would follow that the terms
Vi add little to the description ofthe data,
once the terms 1M1 and Tt lhave been in-
cluded. Thuts one may measure the
importance of prognostic factors by the
lifferences in the goodness-of-fit criteria of
the 2 appropriately chosen models.
The method can be used in a similar
way to examine simultaneously the im-
portance of several prognostic factors.
The analysis was carried out using the
GLIM programme package (Nclder, 1974)
that is available on the main Liverpool
University computer, an ICL 19068.
Unfortunately, at the time of analysis
there were restrictions on tle storage space
allowed to GLIM at Liverpool University,
and as a result the analvsis had to be per-
formed in piecemeal fashion, assessing the
prognostic factors three at a time instead
of all at once.
As mentioned in the maini text, the data
were analysed in two parts; firstly in-
cluding all 3085 records, and secondly the
TABLE AL -Results offitting Brown's miodel to the data
of 3085 patients
Measure of
importaincet
(relevant
Goodness- Degrecs factor
of-fit of show!ln in
AModel§ criteria freedom P* )arentheses)
AM 618-9 71 <0-0(001
I +T 274-0 66 <0-0001 59-0 (T)
M+T+-S 171-3 64 <0-0001 51-3 (8)
M+T+G 193-1 63 <0-0001 27-0 (G)
M-FT+S-G 96-95 61 <0-0001
AI+T+S+G+T.8 82-06 51 0 004 1-5 (T.S.)
MA+T+S+G+±T.G 42-67 46 (059 ,3 6 (T.G.)
M+T+S+G+T.S+T.G 27-46 36 0-84
§ A value ofP which is less than 0-05 irnplies that the model does n1ot ad(leluately
fit the data.
t Calculated as the reduction in the goo(lness-of-fit criterion achieved by
addling the factor into the model dividte(d by the reductionl in the (legrees offreedom.
§ M =Overall mean, T -Time period, S=Clinical stage, G=Histological grade.
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TABLE A2.-Results offitting Brown's model to the data of 1759
patients with histological grade
Measure
Degrees of
Goodness- of importance
Model of-fit freedom P (Factor)
M 424-6 53 <0-0001
M+T 190-5 48 <0 0001 46-8 (T)
M+T+S 144-6 46 <0-0001 22-9 (S)
M+T+G 109-4 46 <00001 405 (G)
M+T+S+G 7057 44 0007
M+T+S-+G+T.S 61-33 34 0-003 0-9 (T.S)
M+T+S+G+T.G 25-33 34 0-86 3-6 (T.G)
M+T+S+G+T.S+T.G 16-27 24 0-88
Abbreviations as for Table Al.
subset of 1759 records with a histological
grade.
APPENDIX 2.-RESULTS OF ANALYSIS
USING BROWN S MODEL
The factors were assessed in the follow-
ing combinations:
(i)
(ii)
Time, clinical stage,
grade
Time, clinical stage,
grade, age
(iii) Time, clinical stage,
grade, tumour size.
histological
histological
histological
The first combination was chosen be-
cause it was clear from published work and
from a preliminary scan of our data that
time, stage and grade would have to be
included in our model. Each of the other
prognostic factors were then added to
determine whether it made any further
contribution to the prediction of survival.
This approach is not normally recom-
mended but in this study we were forced
into it by the restrictions in the use of
GLIM on the Liverpool computer.
In the analysis of each combination of
factors the models were considered in a
sequence similar to the models A2a-A2c.
The goodness-of-fit criterion was obtained
for each model examined. The results of
the analysis of Combination (i) are shown
in Tables Al and A2, which refer to the
analysis of all 3085 patients and the
smaller group ofpatients with histological
grades respectively. These tables show the
goodness-of-fit criteria with their corres-
ponding degrees of freedom and prob-
ability levels. The latter are calculated
assuming that the criterion has a chi-
squared distribution with the given de-
grees offreedom. The final column gives a
value (based on the difference between the
goodness-of-fit criteria of two models)
which measures the importance ofa factor
or an interaction between two factors.
Tables Al and A2 show that, as well as
the main effects of time, stage and grade,
the interaction of time and grade is re-
quired in the model. It was the latter
result which led to our plotting Fig. 4
and 5 of the main text. The order of im-
portance of stage and grade is reversed in
the two tables. This was because the
analysis of Table Al included an extra
histological grade, classified as unknown,
and this inevitably "muddied" the con-
tribution played by grade. The com-
parison of the importance of stage and
grade in Table A2 is therefore the more
reliable (but see the Discussion section in
the main text for further comments).
The prognostic factor tumour size was
not found to be of any importance, once
grade and stage were included in the
model. Age, however, was of importance,
both as a main effect and also through an
age-grade interaction. It was found that
on further analysis, when deaths from
malignant disease only were considered,
the contribution of age became negligible,
although time, stage, grade and the time-
grade interaction remained important.
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We concluded therefore that the age
effect was due to deaths from non-
malignant disease in old age. In the
interests of brevity the results of these
analyses are not included.
APPENDIX 3.-EFFECT OF INCLUDING
HISTOLOGICAL GRADE IN ANALYSING
THE RESULTS OF A CLINICAL TRIAL
Suppose we enter 2N patients wvith
Clinical Stage 2 disease into our trial. Let
N patients receive the conventional treat-
ment (A) and N receive the alternative
treatment (B). Suppose also that in the
total group of 2N patients, the number
with histological grades I, II and III are
0-5N, N and 0-5N respectively. Finally,
suppose that experience shows that the
5-year survival rate for patients with
Grades I, II and III following conven-
tional therapy (A) are 71%, 43% and 24%
respectively. These figures are taken from
Bloom (1962).
We will consider a comparison of Treat-
ments A and B based on 5-year survival
rates. Normally one would use the sur-
vival times themselves in any treatment
comparison (Peto et al., 1977). However,
we use here the cruder method of comr-
paring the 5-year rates for the sake of
simplicity.
Assume firstly that no knowledge of
histological grade has been obtained for
this trial. Then the expected 5-year
survival rate in the treatment Group Ais:
(0.25 x 71%)+(0O5 x 43%)+(025 x 24%)
=45.25%
Under the null hypothesis (that there is
no difference between treatments) the
standard error of the difference in pro-
portions is:
I2 x45.25% x 54 75% 70 4%
N VN
Now assume that the histological grade is
known for each patient in the trial. Let
the numbers of Grade Is, IIs and Ills be
ni, n2, n3, in treatment Group A, and m1,
M2, M3 in treatment Group B. We may
now use Cochran's (1954) test to compare
the treatments. We compute d, given by:
_ 3 3
I widil E wi
i=1 i=l1
where di is the difference in survival rates
of the two treatment groups for Histo-
logical Grade i (i-1, 2, 3) and
Suppose that an equal distribution of
grades has in fact taken place over the
two treatment groups, i.e. ni=m1, n2`m2,
n3=M3 (small departures from this
assumption do not alter the validity ofthe
argument). Then:
wi=ni/2, ni=025N, n2=-O5N
and n3=-0'25N
and the expression for d reduces simply to
the difference in the 5-year survival rates
of the two groups as before. However, the
standard error of d now becomes equal to:
V/2[(0o25 x 71% X 29%)+(05 x43%
x 57%)+(0.25 x 24% x 76%)]/N
66.3%
Therefore N patients and a knowledge of
their histological grade gives as much
accuracy in the comparison as N' patients
without a knowledge of their grade where
66-3 70*4.
VN\V\iN' e where N'= 113 N
Thus we have the equivalent of 13% more
patients in the trial.
REFERENCES
ARMITAGE, P. (1971) Statistical Methods in Medical
Research, Ch. 14, Oxford: Blackwell.
ARMITAGE, P. & GEHAN, E. A. (1974) Statistical
methods for the identification and use ofprognostic
factors. Int. J. Cancer, 13, 16.
BLOOM, H. J. G. (1950) Prognosis in carcinoma ofthe
breast. Br. J. Cancer, 4, 259.
BLOOM, H. J. G. (1962) The role ofhistological grad-
ing in the study of breast cancer. In SymposiUm
on thePrognosis ofMalignant Tumours of the Breast
Ed. P. Denoix & C. Rouquette. UICC Acta, 18,
842.HISTOLOGICAL GRADE IN BREAST CANCER 55
BLOOM, H. J. G. & RICHARDSON, W. W. (1957)
Histological gradingandprognosis inbreast cancer.
Br. J. Cancer, 11, 359.
BONADONNA, G., BRUSAMOLINO, E., VALAGUSSA, P.
& 8 others (1976) Combination chemotherapy as an
adjuvant treatment in operable breast cancer.
New Eng. J. Med., 294, 405.
BROWN, C. C. (1975) On the use ofindicator variables
for studying the time-dependence of parameters
in a response-time model. Biometrics, 31, 863.
BUNTING, J. S., HEMSTED, E. H. & KREMER, J. K.
(1976) The pattern of spread and survival in 596
cases of breast cancer related to clinical staging
and histological grade. Clin. Radiol., 27, 9.
COCHRAN, W. G. (1954) Some methods for streng-
thening the common x2 tests. Biometrics, 10, 417.
FISHER, B., CARBONE, P., EcoNoMoY, S. G. & 9
others (1975) I-Phenylalanine mustard (L-PAM)
in the management of primary breast cancer.
New Engl. J. Med., 292, 117.
FISHER, E. R. & FISHER, B. (1977) Relationship of
pathologic and some clinical discriminants to the
spread of breast cancer. Int. J. Radiat. Oncol.
Biol. Phys., 2, 747.
FOOTE, F. W. (1959) Surgical pathology of cancer of
the breast. In Cancer of the Breast, Ed. W. H.
Parsons. Oxford: Blackwell. p. 59.
HAUSEMANN, D. VON (1892) Uber die Anaplasie der
Geschwulstzellen und die assymetrische Mitose.
Virchows Arch. Path. Anat., 129, 436.
HARTVEIT, F. (1971) Prognostic typing in breast
cancer. Br. Med. J., 4, 253.
MULTICENTRE BREAST CANCER CHEMOTHERAPY
GROUP (1977) Multimodal therapy for histological
stage II breast cancer. Lancet, ii, 396.
NELDER, J. (1974) General Linear Interactive Model-
ling (GLIM). Oxford: National Algorithms Group.
PETO, R., PIKE, M. C., ARMITAGE, P. & 7 others
(1977). Design and analysis of randomised clinical
trials requiring prolonged observation of each
patient. II. Analysis and examples. Br. J. Cancer,
35, 1.
SCARFF, R. W. & TORLONI, H. (1968) Histological
typing of breast tumours. International Classi-
fication of Tumours 2, 19 Geneva: W.H.O.
SCHIODT, T (1966) Breast Carcinoma. A Histologic
and Prognostic Study of 650 Followed-up Cases.
Copenhagen: Munksgaard.